CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 72 enrolled
Drug / intervention
positron emission tomography +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02084147
NCT02084147N/ACompleted

PET-MRI: Evaluation, Optimization and Clinical Implementation

Case Comprehensive Cancer Center·interventional·Posted Mar 11, 2014·Updated Oct 29, 2019

In Brief

A clinical study evaluating positron emission tomography, computed tomography, and 1 other intervention for Cardiac Disease and 6 related conditions. Completed, enrolled 72 participants across 1 site.

Detailed Summary

This randomized pilot clinical trial studies how well positron emission tomography (PET)-magnetic resonance imaging (MRI) works compared to standard-of-care PET-computed tomography (CT) in diagnosing patients with cancer, cardiac diseases, or neurologic diseases. PET-MRI combines two imaging methods that can be used to evaluate disease. PET-MRI is similar to standard-of-care PET-CT, but exposes the patient to less radiation. It is not yet known whether PET-MRI produces better image quality than PET-CT in diagnosing patients with cancer, cardiac disease, or neurologic disease.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedMar 11, 2014
Enrollment StartMar 7, 2013
Primary CompletionSep 14, 2016
Study CompletionOct 2, 2018
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 12.3 years ago

Interventions

positron emission tomographydevice

Undergo PET

computed tomographydevice

Undergo CT

magnetic resonance imagingdevice

Undergo MRI